O. B. Ustinnikova

O. B. Ustinnikova

Auto-generated profile, based on publicly available information

O. B. Ustinnikova

Scientific Centre for Expert Evaluation of Medicinal Products

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2018 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
OROlga Rounova
Olga Rounova
PDPeter Demin
Peter Demin
MKMikhail Korotkov
Mikhail Korotkov
VMVictoriya Malkova
Victoriya Malkova
OUOlga Ustinnikova
Olga Ustinnikova

9 November 2018 in Pharmaceutical Chemistry Journal
Verified
Journal Article
Closed access
PDF file
EGE. O. Goloshchapova
E. O. Goloshchapova
ORO. B. Runova
O. B. Runova
OUO. B. Ustinnikova
O. B. Ustinnikova

1 March 2024 in Biological Products. Prevention, Diagnosis, Treatment
Verified
Journal Article
Open access
PDF file
RVR. A. Volkova
R. A. Volkova
OFO. V. Fadeikina
O. V. Fadeikina
OUO. B. Ustinnikova
O. B. Ustinnikova
KSK. A. Sarkisyan
K. A. Sarkisyan
AMA. A. Movsesyants
A. A. Movsesyants
VKV. V. Kosenko
V. V. Kosenko
SCIENTIFIC RELEVANCE.The use of appropriately certified reference standards (RSs) is a necessary element of analytical procedure standardisation that ensures comparability of results across different laboratories assessing the quality of medicines, which is important for the quality control of biologicals. Marketing authorisation involves providing information on RSs, but no specific requirements are given for the relevant section of the dossier. Therefore, it is necessary to develop the requirements for the appropriate guidelines.AIM.This study aimed to develop specific requirements for the materials that should be included in the Reference Standards section of the dossier for a biological product.DISCUSSION.The authors analysed national and international regulatory frameworks governing RSs for biologicals, including documents by the World Health Organisation (WHO), the Eurasian Economic Union, the International Organisation for Standardisation (ISO), and the Russian Federal Agency for Technical Regulation and Metrology. Additionally, the authors analysed the experience of RS certification and use at the Scientific Centre for Expert Evaluation of Medicinal Products. This article covers specific aspects of biological RS certification, considering the differences between measurement techniques and analytical procedures. The authors formulated the key requirements for the documents submitted in the dossier section on RSs for biologicals (biological reference materials). The methods (analytical procedures) used for RS certification should be described in accordance with the requirements for standard operating procedures. Adequate validation studies should establish the necessary validation characteristics of these analytical procedures. Additionally, this article presents the requirements developed to certify primary RSs for structure confirmation of proteins in novel biologicals. The values of certified characteristics and critical quality indicators should be established, and the RS production technology should be described and in compliance with WHO recommendations and/or Good Manufacturing Practice (GMP) standards. The basic certification stages are common to all types of RSs. The RS shelf life should be established in real-time stability studies, whereas accelerated stability testing may be useful for studying degradation mechanisms and the effects of short-term deviations from the specified storage conditions. In accordance with WHO recommendations, the Reference Standards section of the registration dossier should specify changes to the RS that require regulatory approval.CONCLUSIONS.The authors believe that the requirements for the materials in the Reference Standards section of the dossier for a biological product, as systematised in this study for inclusion in the relevant guidelines, will provide a unified approach to RS development, certification, and documentation for applicants, developers, and competent authority experts and will streamline RS consideration during marketing authorisation.

1 August 2018 in Pharmaceutical Chemistry Journal
Verified
Journal Article
Closed access
PDF file
OKO. N. Kolesnikova
O. N. Kolesnikova
ORO. B. Runova
O. B. Runova
OUO. B. Ustinnikova
O. B. Ustinnikova

25 June 2018 in Medical Immunology (Russia)
Verified
Journal Article
Open access
PDF file
OUO. B. Ustinnikova
O. B. Ustinnikova
EGE. O. Goloshchapova
E. O. Goloshchapova
ORO. B. Runova
O. B. Runova
MKM. G. Korotkov
M. G. Korotkov
RVR. A. Volkova
R. A. Volkova
РАЗРАБОТКА ПОРЯДКА АТТЕСТАЦИИ СТАНДАРТНОГО ОБРАЗЦА МЕТИОНИОВОЙ ФОРМЫ ИНТЕРФЕРОНА АЛЬФА-2b ДЛЯ ПОДТВЕРЖДЕНИЯ ПОДЛИННОСТИ МЕТОДОМ ПЕПТИДНОГО КАРТИРОВАНИЯ

21 February 2023 in Biological Products. Prevention, Diagnosis, Treatment
Verified
Journal Article
Open access
PDF file
AMA. S. Minero
A. S. Minero
ORO. B. Rounova
O. B. Rounova
OUO. B. Ustinnikova
O. B. Ustinnikova
Carbohydrate compounds are widely used as fillers and stabilisers in biological products. When present, these compounds guarantee that the active pharmaceutical ingredient will remain stable during production, transportation, and storage. At the same time, pharmacopoeias standardise the excipient content and require that excipients should be quantified for assessing the quality of biological products.The aim of the study was to identify promising methods for the development of quantification procedures for carbohydrate compounds in biological products.The authors analysed regulatory documents for biological products approved in the Russian Federation. The most widely used excipients, both individually and in combinations, are polyols (sorbitol and mannitol), monosaccarides (glucose), and disaccharides (trehalose, sucrose, lactose, and maltose). Using literature data, the authors reviewed the methods used for quantifying polyols, monosaccharides, and disaccharides to assess the quality of biological products. Quantitative determination of carbohydrate stabilisers employs titrimetric, spectrophotometric, enzymatic, and chromatographic methods. This review presents an analysis of the advantages and disadvantages of these methods. It highlights the advantages of ionic HPLC with amperometric detection and hydrophilic HPLC with refractometric and evaporative light scattering detection, which are sufficiently selective and can identify substances without prior derivatisation. In conclusion, ionic and hydrophilic HPLC methods are a promising base for the development of quantification procedures for carbohydrate stabilisers.